Partner
Mareesa Frederick 律师的执业重点是复杂的高风险知识产权诉讼,尤其是美国国际贸易委员会(ITC)的337条款诉讼程序。她曾被《The Legal 500 U.S.》评为美国国际贸易委员会专利诉讼的“下一代律师”代表人物。此外,在向客户提供预审策略、战略许可机会和专利组合咨询服务领域,Mareesa也积累了丰富的经验。
Mareesa处理过众多技术领域的诉讼,包括化妆品、医药产品、制造工艺、生物技术、聚合物、半导体芯片和包装、运动疗法设备、可调谐激光器、移动电话、数码相机、电视和电脑显示器、喷墨墨盒、印刷板、LED照明和汽车零件。她还处理过外观设计专利、商标、商业秘密和商业外观索赔等诉讼案件。
在加入本所之前,Mareesa是美国国际贸易委员会的一名高级调查律师,在美国国际贸易委员会的众多337条款案件中担任首席政府法律顾问,涉及机械、电气和消费品相关专利。此外,她还曾在美孚化工薄膜事业部任职,在聚合物加工领域积累了丰富的技术经验,曾在该事业部担任研发工程师和工艺工程师。
Mareesa投入了大量的时间从事无偿法律援助。最近,Capital Pro Bono Honor Roll表彰了她的贡献。她通过华盛顿无家可归者法律诊所(Washington Legal Clinic for the Homeless)代理客户,并参与了飞翰的刑事法律援助计划,在华盛顿高等法院为客户提供代理服务。目前,她的无偿法律援助工作的重点是支持有特殊教育需求的儿童,她在飞翰领导建立正式特殊教育项目的相关事宜。
除了飞翰的专利执业外,Mareesa还担任霍华德大学的兼职教授六年,为工程专业的学生教授专利法,还曾在霍华德大学法学院担任兼职教授两年,教授专利法和专利政策课程。Mareesa的卓越贡献获得了《National Law Journal》的认可,该杂志称她为华盛顿地区“冉冉升起的明星”。
重要经历
会员身份
Eli Lilly and Company v. Actavis Labs. UT Inc.
Represented Eli Lilly in patent litigation relating to Cialis®.
1:16-cv-01119, E.D. Va., Judges Nachmanoff, Trenga
Actelion Pharmaceuticals v. ICOS Corp.
Represented ICOS in Patent Trial and Appeal Board (PTAB) proceeding involving pharmaceutical formulation.
IPR2015-00561, -00562, PTAB, Judges Mitchell, Snedden, Yang
Eli Lilly and Company v. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Represented Eli Lilly in an appeal from a PTAB decision in an IPR case.
IPR2014-00693, -00752, PTAB, Judges Green, Prats, Snedden
16-1547, Fed. Cir., Judges Bryson, Moore, Newman
Nippon Steel & Sumitomo Metal Corp. v. POSCO
Defended POSCO in a patent infringement action involving grain oriented steel.
2:12-cv-02429, D.N.J., Judges Cavanaugh, Chesler, Falk, Waldor
15-0112, Fed. Cir., Judges Dyk, Hughes, Newman
In Re Certain Polycrystalline Diamond Compacts and Articles Containing Same
Secured a decisive victory for client US Synthetic Corp. (USS) at the ITC. After a full hearing, the ALJ found that respondents infringed multiple claims of USS’s patent and that the claims were valid and supported by a domestic industry, but an initial Commission ruling under § 101 temporarily prevented a finding of violation of Section 337. The Federal Circuit reversed the § 101 ruling, and on remand the ITC found a violation and issued a limited exclusion order barring infringing polycrystalline diamond products from entry into the United States, securing final relief for USS.
337-TA-1236, ITC, Judge Elliot
Certain Drug Products Containing C-Type Natriuretic Peptide Variants, and Components Thereof
Representing respondent Wacker Biotech GmbH in a rare section 337 ITC investigation involving drug products containing C-type natriuretic peptide variants.
337-TA-1447, ITC, Judge Cheney
Conference
International Trade Commission Litigation & Enforcement International Trade Commission Litigation & Enforcement
May 4-5, 2026
Washington, DC
Conference
2026 American Bar Association-Intellectual Property Law Section Annual Meeting 2026 American Bar Association-Intellectual Property Law Section Annual Meeting
April 15-16, 2026
Washington, DC
Articles
Why Fashion Brands are Doubling Down on US Utility Patents Why Fashion Brands are Doubling Down on US Utility Patents
March 10, 2026
World Trademark ReviewArticles
Your Best Bet for Enforcement: Schedule A Cases or Section 337 Investigations? Your Best Bet for Enforcement: Schedule A Cases or Section 337 Investigations?
November 27, 2025
World Trademark Review“Mareesa Frederick is especially noted for her work before the ITC, regularly leading complex investigations.”
Intellectual Asset Management Patent 1000
"Frederick has a sterling track record at the ITC, where she previously worked as a senior investigative attorney."
Intellectual Asset Management Patent 1000
“Mareesa Frederick is 'deeply familiar with the ITC practice and greatly contributes to the resolution of complicated problems, which occasionally arise during ITC proceedings.’”
Legal 500 United States
“Frederick, who also benefits from inside knowledge, recently won a rare complete victory on summary determination for REC Solar Holdings as respondent in a high-profile investigation involving solar cells.”
Intellectual Asset Management Patent 1000
“Mareesa Frederick is especially noted for her work before the ITC, regularly leading complex investigations.”
Intellectual Asset Management Patent 1000
"Frederick has a sterling track record at the ITC, where she previously worked as a senior investigative attorney."
Intellectual Asset Management Patent 1000
“Mareesa Frederick is 'deeply familiar with the ITC practice and greatly contributes to the resolution of complicated problems, which occasionally arise during ITC proceedings.’”
Legal 500 United States
“Frederick, who also benefits from inside knowledge, recently won a rare complete victory on summary determination for REC Solar Holdings as respondent in a high-profile investigation involving solar cells.”
Intellectual Asset Management Patent 1000
Award/Ranking
Finnegan Earns Top Rankings in the 2026 Legal 500 U.S. Guide Finnegan Earns Top Rankings in the 2026 Legal 500 U.S. Guide
June 10, 2026
The Legal 500Award/Ranking
Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked
May 28, 2026
Intellectual Asset Management (IAM)Award/Ranking
61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll 61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll
May 7, 2026
Commentary
How Litigation Funding Disclosure Could Affect ITC Cases How Litigation Funding Disclosure Could Affect ITC Cases
May 7 , 2026
Law360Commentary
Patent Cases Down 64% YOY at PTAB, up 70% at ITC in Q1 2026 Patent Cases Down 64% YOY at PTAB, up 70% at ITC in Q1 2026
April 15, 2026
Intellectual Asset Management (IAM)Commentary
ITC Commissioner Nominations Could Create a Republican Majority ITC Commissioner Nominations Could Create a Republican Majority
February 13, 2026
Intellectual Asset Management (IAM)Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.